Question 1

What's the Glenmark Pharmaceuticals Ltd share price today?

Accepted Answer

Glenmark Pharmaceuticals Ltd share price was Rs 2,381.40 at 04:01 PM IST on 6th May 2026. Glenmark Pharmaceuticals Ltd share price was down by 2.04% from the previous closing price of Rs 2,431.00. Glenmark Pharmaceuticals Ltd share price trend:

Last 1 Month: Glenmark Pharmaceuticals Ltd share price moved up by 12.98% on BSE
Last 3 Months: Glenmark Pharmaceuticals Ltd share price moved up by 22.92% on BSE
Last 12 Months: Glenmark Pharmaceuticals Ltd share price moved up by 69.21% on BSE
Last 3 Years: Glenmark Pharmaceuticals Ltd price moved up by 331.51% on BSE

Question 2

How can I quickly analyse the performance of the Glenmark Pharmaceuticals Ltd stock?

Accepted Answer

The performance of the Glenmark Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 63.00
Price to book value ratio is 7.00
Dividend yield of 0.10
The EPS (trailing 12 months) of the Glenmark Pharmaceuticals Ltd stock is Rs 37.74

Question 3

What is the market cap of Glenmark Pharmaceuticals Ltd?

Accepted Answer

Glenmark Pharmaceuticals Ltd has a market capitalisation of Rs 67,203 crore.

Question 4

What is Glenmark Pharmaceuticals Ltd's 52-week high/low share price?

Accepted Answer

The Glenmark Pharmaceuticals Ltd’s 52-week high share price is Rs 2,471.05 and 52-week low share price is Rs 1,340.35.

Question 5

Is the Glenmark Pharmaceuticals Ltd profitable?

Accepted Answer

On a consolidated basis, Glenmark Pharmaceuticals Ltd reported a profit of Rs 403.23 crore on a total income of Rs 3,945.08 crore for the quarter ended 2025. For the year ended Dec 2025, Glenmark Pharmaceuticals Ltd had posted a profit of Rs 403.23 crore on a total income of Rs 3,945.08 crore.

Question 6

Which are Glenmark Pharmaceuticals Ltd’s peers in the Health care sector?

Accepted Answer

Glenmark Pharmaceuticals Ltd’s top 5 peers in the Health care sector are  Mankind Pharma, Zydus Lifesci., Aurobindo Pharma, Glenmark Pharma., Alkem Lab, Laurus Labs, Biocon.

Question 7

Who owns how much in Glenmark Pharmaceuticals Ltd?

Accepted Answer

Key changes to the Glenmark Pharmaceuticals Ltd shareholding are as follows:

Promoter holding in Glenmark Pharmaceuticals Ltd has gone up to 46.65 per cent as of Mar 2026 from 46.65 per cent as of Jun 2025.
Foreign Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone down to 20.35 per cent as of Mar 2026 from 20.62 per cent as of Jun 2025.
Mutual Funds Uti holding in Glenmark Pharmaceuticals Ltd has gone up to 16.80 per cent as of Mar 2026 from 15.55 per cent as of Jun 2025.
Indian Public holding in Glenmark Pharmaceuticals Ltd has gone down to 10.32 per cent as of Mar 2026 from 11.68 per cent as of Jun 2025.
Non Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone down to 3.36 per cent as of Mar 2026 from 3.38 per cent as of Jun 2025.
Other Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone down to 1.46 per cent as of Mar 2026 from 1.67 per cent as of Jun 2025.
Insurance Companies holding in Glenmark Pharmaceuticals Ltd has gone up to 1.00 per cent as of Mar 2026 from 0.46 per cent as of Jun 2025.
Financial Institutions holding in Glenmark Pharmaceuticals Ltd has gone up to 0.06 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.
Custodians holding in Glenmark Pharmaceuticals Ltd has gone up to 0.00 per cent as of Mar 2026 from 0.00 per cent as of Jun 2025.

Market Cap (₹ Cr)	67,203
Traded Value (₹ Cr)	14.17
Volume (Shares)	59,489
Face Value (₹)	1

52-Week High (₹)	2,471.05
52-Week High Date	29-Apr-2026
52-Week Low (₹)	1,340.35
52-Week Low Date	05-May-2025

All Time High (₹)	2,471.05
All Time High Date	29-Apr-2026
All Time Low (₹)	1.89
All Time Low Date	10-Feb-2000

Glenmark Pharmaceuticals Share Price

Glenmark Pharmaceuticals Ltd